Get started
Author

Agatha N. Jassem

Observed names: A Jassem, A. Jassem, A.N. Jassem, Agatha Jassem, Agatha N Jassem, JASSEM, Agatha, Jassem A, Jassem, Agatha, Jassem, Agatha N., Jassem, Agatha Natalie
Observed institutions: National Institutes of Health, Canadian Food Inspection Agency, University of British Columbia, Provincial Health Services Authority, University of Toronto, Kelowna General Hospital, Hospital for Sick Children, St. Paul's Hospital, BC Centre for Disease Control, University of Saskatchewan, Victoria General Hospital, BC Children's Hospital, National Institutes of Health Clinical Center, University of Manitoba, University of Birmingham
ORCID: 0000-0002-4128-2919
Observed ORCID: 0000-0002-4128-2919
OpenAlex ID: A5029577244
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada
2022 · Danuta M Skowronski, Yossi Febriani, et al. · Clinical Infectious Diseases · 153
PDF
Mapping SARS-CoV-2 antigenic relationships and serological responses
2023 · Samuel H. Wilks, Barbara Mühlemann, et al. · Science · 145
PDF
Critical Illness in an Adolescent with Influenza A(H5N1) Virus Infection
2024 · Agatha N. Jassem, Ashley Roberts, et al. · New England Journal of Medicine · 111
Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018
2018 · Danuta M Skowronski, Catharine Chambers, et al. · Eurosurveillance · 94
PDF
Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017
2017 · Danuta M Skowronski, Catharine Chambers, et al. · Eurosurveillance · 70
PDF
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)
2024 · Danuta M Skowronski, Yuping Zhan, et al. · Eurosurveillance · 66
PDF
Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV)
2019 · Danuta M Skowronski, Suzana Sabaiduc, et al. · Eurosurveillance · 65
COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report
2021 · Wayne F. Leung, Samuel Chorlton, et al. · International Journal of Infectious Diseases · 61
A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2
2021 · Abdelilah Majdoubi, Christina Michalski, et al. · JCI Insight · 58
PDF
Clinical Performance of Check-Direct CPE, a Multiplex PCR for Direct Detection of bla KPC , bla NDM and/or bla VIM , and bla OXA-48 from Perirectal Swabs
2015 · Anna F. Lau, Gary A. Fahle, et al. · Journal of Clinical Microbiology · 53
Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018
2018 · Danuta M Skowronski, Catharine Chambers, et al. · Clinical Infectious Diseases · 48
PDF
Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016–2017 and 2017–2018 Epidemics in Canada
2020 · Danuta M Skowronski, Siobhan Leir, et al. · The Journal of Infectious Diseases · 46
PDF
Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada
2021 · Danuta M Skowronski, Solmaz Setayeshgar, et al. · Clinical Infectious Diseases · 45
PDF
Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23
2023 · Danuta M Skowronski, Erica SY Chuang, et al. · Eurosurveillance · 44
PDF
Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020
2020 · Danuta M Skowronski, Macy Zou, et al. · Eurosurveillance · 40
PDF
In Vitro Susceptibility of Burkholderia vietnamiensis to Aminoglycosides
2011 · Agatha N. Jassem, James E. A. Zlosnik, et al. · Antimicrobial Agents and Chemotherapy · 39
PDF
Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010–2011 to 2016–2017
2020 · Danuta M Skowronski, Macy Zou, et al. · Clinical Infectious Diseases · 36
PDF
Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals
2022 · Brian Grunau, Martin Prusinkiewicz, et al. · Microbiology Spectrum · 34
Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?
2018 · Catharine Chambers, Danuta M Skowronski, et al. · Open Forum Infectious Diseases · 32
PDF
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval
2021 · Brian Grunau, Michael Asamoah-Boaheng, et al. · Clinical Infectious Diseases · 30
PDF
A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG
2021 · Fang Fang Li, Aaron Liu, et al. · Journal of Clinical Virology · 25
PDF
Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026
2026 · Lea Separovic, Suzana Sabaiduc, et al. · Eurosurveillance · 24
PDF
Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January–April 2021
2021 · Catherine A. Hogan, Agatha N. Jassem, et al. · Emerging infectious diseases · 24
PDF
The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada
2021 · Aidan M. Nikiforuk, Kevin S. Kuchinski, et al. · EBioMedicine · 24
PDF
Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada
2022 · Shinhye Kim, Erica SY Chuang, et al. · Eurosurveillance · 22
PDF
Works count: 138
Citation count: 1,930
H-index: 24
I10-index: 50
Year
Topic
Type